Filing Details
Curanex Pharmaceuticals Inc (NASDAQ:CURX) filed a Form 8-K with the Securities and Exchange Commission on October 19, 2026, disclosing a material event.
8k filedNASDAQ:CURX
Curanex Pharmaceuticals Inc (CURX) Reports Material Event to SEC
Curanex Pharmaceuticals Inc (NASDAQ:CURX) filed a Form 8-K with the Securities and Exchange Commission on October 19, 2026, disclosing a material event.
At publication ·
What changed
Curanex Pharmaceuticals Inc (NASDAQ:CURX) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Curanex Pharmaceuticals Inc filed a Form 8-K with the SEC on October 19, 2026, disclosing a material event requiring shareholder notification.
- The company's stock trades at $4.92 with a market capitalization of $12.5 million.
- Material events in 8-K filings can include leadership changes, acquisitions, asset sales, or financial guidance modifications.
- The article does not specify the nature of Curanex's disclosed material event or its potential impact.
Market Context
Curanex Pharmaceuticals Inc's stock currently trades at $4.92 with a market capitalization of $12.5M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Curanex Pharmaceuticals Inc's stock.
All SEC filings for Curanex Pharmaceuticals Inc are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CURX Stock Page
Frequently Asked Questions
Where can I read CURX's SEC filings?
Browse all filings on our CURX SEC filings page.
What types of SEC filings does Curanex Pharmaceuticals Inc file?
Public companies like Curanex Pharmaceuticals Inc file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.